RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Simcere Pharmaceutical Group Stock

Simcere Pharmaceutical Group Liabilities 2024

Simcere Pharmaceutical Group Liabilities

3.63 B CNY

Ticker

2096.HK

ISIN

HK0000658531

WKN

A2QD9S

In 2024, Simcere Pharmaceutical Group's total liabilities amounted to 3.63 B CNY, a -0.72% difference from the 3.66 B CNY total liabilities in the previous year.

Simcere Pharmaceutical Group Aktienanalyse

What does Simcere Pharmaceutical Group do?

Simcere Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Simcere Pharmaceutical Group's Liabilities

Simcere Pharmaceutical Group's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Simcere Pharmaceutical Group's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Simcere Pharmaceutical Group's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Simcere Pharmaceutical Group's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Simcere Pharmaceutical Group’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Simcere Pharmaceutical Group stock

What is the level of liabilities of Simcere Pharmaceutical Group this year?

Simcere Pharmaceutical Group has a debt balance of 3.63 B CNY this year.

What were the liabilities of Simcere Pharmaceutical Group compared to the previous year?

The liabilities of Simcere Pharmaceutical Group have increased by -0.72% dropped compared to the previous year.

What are the consequences of high debt for investors of Simcere Pharmaceutical Group?

High liabilities can pose a risk for investors of Simcere Pharmaceutical Group, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Simcere Pharmaceutical Group?

Low liabilities mean that Simcere Pharmaceutical Group has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Simcere Pharmaceutical Group affect the company?

An increase in liabilities of Simcere Pharmaceutical Group can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Simcere Pharmaceutical Group affect the company?

A decrease in the liabilities of Simcere Pharmaceutical Group can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Simcere Pharmaceutical Group?

Some factors that can influence the liabilities of Simcere Pharmaceutical Group include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Simcere Pharmaceutical Group so important for investors?

The liabilities of Simcere Pharmaceutical Group are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Simcere Pharmaceutical Group take to modify the liabilities?

To change its liabilities, Simcere Pharmaceutical Group can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Simcere Pharmaceutical Group pay?

Over the past 12 months, Simcere Pharmaceutical Group paid a dividend of 0.18 CNY . This corresponds to a dividend yield of about 2.71 %. For the coming 12 months, Simcere Pharmaceutical Group is expected to pay a dividend of 0.19 CNY.

What is the dividend yield of Simcere Pharmaceutical Group?

The current dividend yield of Simcere Pharmaceutical Group is 2.71 %.

When does Simcere Pharmaceutical Group pay dividends?

Simcere Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Simcere Pharmaceutical Group?

Simcere Pharmaceutical Group paid dividends every year for the past 0 years.

What is the dividend of Simcere Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.19 CNY are expected. This corresponds to a dividend yield of 2.91 %.

In which sector is Simcere Pharmaceutical Group located?

Simcere Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Simcere Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Simcere Pharmaceutical Group from 7/15/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.

When did Simcere Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 7/15/2024.

What was the dividend of Simcere Pharmaceutical Group in the year 2023?

In the year 2023, Simcere Pharmaceutical Group distributed 0.176 CNY as dividends.

In which currency does Simcere Pharmaceutical Group pay out the dividend?

The dividends of Simcere Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Simcere Pharmaceutical Group

Our stock analysis for Simcere Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Simcere Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.